Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71.9M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
13.5M
-
Shares change
-
-164K
-
Total reported value, excl. options
-
$79.6M
-
Value change
-
-$1.06M
-
Number of buys
-
1
-
Number of sells
-
-4
-
Price
-
$6.47
Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q2 2024
12 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q2 2024.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.5M shares
of 71.9M outstanding shares and own 18.78% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (11.8M shares), RENAISSANCE TECHNOLOGIES LLC (1.31M shares), Neumann Advisory Hong Kong Ltd (316K shares), GEODE CAPITAL MANAGEMENT, LLC (27.7K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (16.4K shares), WELLS FARGO & COMPANY/MN (12.5K shares), MORGAN STANLEY (7.82K shares), UBS Group AG (1.56K shares), GROUP ONE TRADING, L.P. (412 shares), and Horizon Investments, LLC (52 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.